The Humoral Anti-Islet Immune Response: Immunochemical Studies of Glycoconjugate Antigens

[1]  G. Eisenbarth,et al.  Binding of Cytoplasmic Islet Cell Antibodies Is Blocked by Human Pancreatic Glycolipid Extracts , 1988, Diabetes.

[2]  L. Mattsson,et al.  Characterization of the binding epitope of a monoclonal antibody to sulphatide. , 1988, The Biochemical journal.

[3]  M. Mihatsch,et al.  Factors associated with early remission of type I diabetes in children treated with cyclosporine. , 1988, The New England journal of medicine.

[4]  G. King,et al.  A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes , 1988, The Journal of experimental medicine.

[5]  L. Wicker,et al.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.

[6]  H. Offner,et al.  Gangliosides induce selective modulation of CD4 from helper T lymphocytes. , 1987, Journal of immunology.

[7]  A. Sher,et al.  Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. , 1987, Journal of immunology.

[8]  G. Eisenbarth,et al.  Expression of Cytoplasmic Islet Cell Antigens by Rat Pancreas , 1987, Diabetes.

[9]  T. Tadakuma,et al.  Application of liposomes to generation of monoclonal antibody to glycosphingolipid: production of monoclonal antibody to GgOse4Cer. , 1987, Journal of biochemistry.

[10]  W. Curatolo The physical properties of glycolipids. , 1987, Biochimica et biophysica acta.

[11]  G. Eisenbarth,et al.  Aging in man. Linear increase of a novel T cell subset defined by antiganglioside monoclonal antibody 3G5 , 1987, The Journal of experimental medicine.

[12]  M. Malaise,et al.  Elevated anti-alpha-galactosyl antibody titres. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmopathy? , 1987, Acta endocrinologica.

[13]  J. Thomas,et al.  Cell surface antigens on rat islet tumors. , 1987, Journal of immunology.

[14]  C. Basbaum,et al.  Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. , 1987, The Journal of biological chemistry.

[15]  G. Eisenbarth,et al.  Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies. , 1987, Diabetes research.

[16]  Y. Uchigata,et al.  Pancreatic islet cell surface glycoproteins containing Gal beta 1- 4GlcNAc-R identified by a cytotoxic monoclonal autoantibody , 1987, The Journal of experimental medicine.

[17]  M. Feldmann,et al.  Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients , 1986, Journal of Neuroimmunology.

[18]  M. Naiki,et al.  Specificities of human heterophile Hanganutziu and Deicher (HD) antibodies to glycosphingolipids and a glycoprotein. , 1986, Journal of biochemistry.

[19]  L. Wicker,et al.  Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.

[20]  E. Antman,et al.  Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. , 1986, The American journal of medicine.

[21]  E. Handman,et al.  The glycoconjugate derived from a Leishmania major receptor for macrophages is a suppressogenic, disease‐promoting antigen in murine cutaneous leishmaniasis , 1986, Parasite immunology.

[22]  G. Eisenbarth,et al.  Islet cell antigens. Initial studies of their biology and function. , 1986, Molecular biology & medicine.

[23]  R. Spiro,et al.  Studies on the glycoprotein nature of the thyrotropin receptor: interaction with lectins and purification of the bovine protein with the use of Bandeiraea (Griffonia) simplicifolia I affinity chromatography. , 1986, Endocrinology.

[24]  C. Heusser,et al.  Non-specific binding of mouse IgM antibodies to lipid antigens , 1985, Journal of Neuroimmunology.

[25]  H. Lassmann,et al.  Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis Demonstration by ELISA and relation to serum in vivo demyelinating activity , 1985, Journal of Neuroimmunology.

[26]  M. Sela,et al.  Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. , 1985, Molecular immunology.

[27]  D. Steiner,et al.  Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA. , 1985, The Journal of biological chemistry.

[28]  R. Brady,et al.  Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Handman,et al.  Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. R. Gamble,et al.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.

[31]  G. Eisenbarth,et al.  “Cytoplasmic” Islet Cell Antibodies: Evidence That the Target Antigen Is a Sialoglycoconjugate , 1985, Diabetes.

[32]  J. Evans,et al.  Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK-1. , 1985, Biochemical and biophysical research communications.

[33]  J. Goding,et al.  The Leishmania receptor for macrophages is a lipid‐containing glycoconjugate. , 1985, The EMBO journal.

[34]  D. Marcus,et al.  A review of the immunogenic and immuno-modulatory properties of glycosphingolipids. , 1984, Molecular immunology.

[35]  C. Greenblatt,et al.  An amphipathic sulphated glycoconjugate of Leishmania: characterization with monoclonal antibodies. , 1984, The EMBO journal.

[36]  M. Nirenberg,et al.  Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue. , 1984, Archives of biochemistry and biophysics.

[37]  R. Titus,et al.  Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. , 1984, Journal of immunology.

[38]  R. Spiro,et al.  Occurrence of alpha-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. , 1984, The Journal of biological chemistry.

[39]  R. Alejandro,et al.  A ganglioside antigen on the rat pancreatic B cell surface identified by monoclonal antibody R2D6. , 1984, The Journal of clinical investigation.

[40]  R. Akeson,et al.  Characterization of monoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic islet cell gangliosides in a solid phase radioassay. , 1984, Endocrinology.

[41]  D. Marcus,et al.  Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. , 1984, Journal of immunology.

[42]  B. Trapp,et al.  IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Tavill,et al.  Biochemical Aspects of Human Disease , 1983 .

[44]  B. Haynes,et al.  Monoclonal Antibodies: Probes for the Study of Autoimmunity and Immunodeficiency , 1983 .

[45]  A. E. Boyd,et al.  Binding of monoclonal antibody A2B5 to gangliosides. , 1983, Biochemical and biophysical research communications.

[46]  S. Witkin,et al.  Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS). , 1983, Clinical and experimental immunology.

[47]  N. Kasai,et al.  The monoclonal antibody A2B5 is specific to ganglioside GQ1c , 1983, Brain Research.

[48]  N. Gregson,et al.  IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy , 1983, Journal of the Neurological Sciences.

[49]  H. Dreyfus New Vistas in Glycolipid Research , 1983 .

[50]  G. Bottazzo,et al.  IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability. , 1983, Clinical and experimental immunology.

[51]  A. Davison,et al.  Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis , 1983, Journal of the Neurological Sciences.

[52]  G. Eisenbarth,et al.  Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. , 1983, The New England journal of medicine.

[53]  V. Mureşan,et al.  Distribution of sialoglycoconjugates on acinar cells of the mammalian pancreas. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  J. Palmer,et al.  Coxsackie B4 infection and islet cell antibodies three years before overt diabetes. , 1982, The Journal of pediatrics.

[55]  G. Eisenbarth,et al.  Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Haynes,et al.  Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.

[57]  A. Tiengo,et al.  FIVE-YEAR FOLLOW-UP OF NON-DIABETES WITH ISLET-CELL ANTIBODIES , 1982, The Lancet.

[58]  J. McNally,et al.  EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.

[59]  H. Offner,et al.  Multi-sialo brain gangliosides are powerful stimulators of active E-rosetting lymphocytes from multiple sclerosis patients , 1981, Journal of the Neurological Sciences.

[60]  H. Hashimoto,et al.  Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. , 1980, The Journal of clinical investigation.

[61]  G. Ellison,et al.  Anti-ganglioside antibodies in multiple sclerosis , 1980, Journal of the Neurological Sciences.

[62]  H. Offner,et al.  Stimulation of active E-rosette forming lymphocytes from multiple sclerosis patients by gangliosides and cerebrosides , 1980, Journal of the Neurological Sciences.

[63]  L. Svennerholm,et al.  A procedure for the quantitative isolation of brain gangliosides. , 1980, Biochimica et biophysica acta.

[64]  M. Nirenberg,et al.  Monoclonal antibody to a plasma membrane antigen of neurons. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Naiki,et al.  Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. , 1977, Biochemical and biophysical research communications.

[66]  D. McFarlin,et al.  Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins , 1977, The Journal of experimental medicine.

[67]  H. E. Hirsch,et al.  Serological reactions against glycolipid-sensitised liposomes in multiple sclerosis , 1976, Nature.

[68]  K. Kano,et al.  Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera. , 1976, Clinical and experimental immunology.

[69]  E. Barnes,et al.  Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. , 1974, Lancet.

[70]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[71]  Å. Lernmark,et al.  The Pancreatic β-Cell Recognition of Insulin Secretagogues: INFLUENCE OF NEURAMINIDASE TREATMENT ON THE RELEASE OF INSULIN AND THE ISLET CONTENT OF INSULIN, SIALIC ACID, AND CYCLIC ADENOSINE 3′:5′-MONOPHOSPHATE , 1974 .

[72]  M. Bornstein,et al.  Cerebroside Antibody Inhibits Sulfatide Synthesis and Myelination and Demyelinates in Cord Tissue Cultures , 1974, Science.

[73]  L. Svennerholm CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.

[74]  N. Maclaren,et al.  Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. , 1988, Autoimmunity.

[75]  Y. Uchigata,et al.  Pancreatic islet cell surface glycoproteins containing Gal beta 1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody. , 1987 .

[76]  M. Rapport,et al.  Present status of the immunology of gangliosides. , 1984, Advances in experimental medicine and biology.

[77]  P. Vitti,et al.  Chapter 12 – Autoimmune Thyroid Disease Studied with Monoclonal Antibodies to the Thyrotropin Receptor , 1983 .

[78]  S. Hakomori Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.

[79]  D. Marcus,et al.  Preparation and properties of antibodies to gangliosides. , 1980, Advances in experimental medicine and biology.

[80]  M. Rapport,et al.  Antibodies to total brain gangliosides: titer and specificity of antisera. , 1980, Advances in experimental medicine and biology.

[81]  M. Naiki,et al.  Detection of antibodies to gangliosides in pathologic human sera. Serum-sickness type heterophile antibodies. , 1980, Advances in experimental medicine and biology.

[82]  D. Adams Thyroid-stimulating autoantibodies. , 1980, Vitamins and hormones.